Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
life sciences
national blog main
san francisco blog main
san francisco top stories
8
×
biotech
new york blog main
boston blog main
national top stories
new york top stories
san francisco
startups
boston top stories
fda
raleigh-durham blog main
san diego blog main
boehringer ingelheim
boston
cancer
clinical trials
eli lilly
indiana blog main
indiana top stories
ipo
johnson & johnson
lung cancer
medical device
san diego top stories
sanofi
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
10x genomics
abbvie
acetylon pharmaceuticals
akouos
alex gorsky
alexion pharmaceuticals
allergan
What
deal
8
×
medicines
bio
companies
developer
expand
help
make
medical
new
plans
rna
startup
tests
abandoning
ability
acquire
acquiring
acquisitions
adding
ago
aiming
aims
ambys
announced
array
auris
babies
baggage
bets
big
billion
biotech
building
builds
business
buy
cancer
cash
ceo
Language
unset
Current search:
deal
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed